DCBLD1 mRNA expression was significantly higher in 502 head and neck cancer patients than those in 44 non-cancer subjects (p < 0.001, Figure 1B) and was also higher in 43 tumor tissue paired with pericarcinous tissue (p < 0.001, Figure 1C). Here, DCBLD1 is linked to neoplasm.